Clinical Trial Update: Milciclib in Combination With Gemcitabine in Advanced NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial update for milciclib in combination with gemcitabine in advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• milciclib (milciclib)

Snippet

Sponsor: Tiziana Life Sciences LTD | Conditions: NSCLC | Phase 2 | Status: UNKNOWN